MARSHBANKS TRACY 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 16, 2018
Insider Transaction Report
Form 4
MARSHBANKS TRACY
Director
Transactions
- Sale
Common Stock
2018-03-14$63.10/sh−1,912$120,647→ 483,801 total(indirect: See Footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $63.00 to $63.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).